Myriad Genetics (MYGN) director awarded 59,701 restricted stock units

Rhea-AI Filing Summary

Newcomer Lee Nisley reported acquisition or exercise transactions in this Form 4 filing.

Myriad Genetics director Lee Nisley Newcomer received a grant of restricted stock units. The Form 4 shows an award of 59,701 shares of common stock-equivalent units at no purchase price under the company’s 2026 Employee, Director and Consultant Equity Incentive Plan.

Each restricted stock unit represents one share of Myriad Genetics common stock and will vest upon the earlier of the first anniversary of the grant date or the next annual meeting of stockholders. After this award, Newcomer directly holds 191,842 shares or share-equivalent units in total.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Newcomer Lee Nisley

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	59,701	$0.00	--

Holdings After Transaction: Common Stock — 191,842 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

RSUs granted: 59,701 units Grant price: $0.00 per unit Total holdings after grant: 191,842 shares +1 more

4 metrics

RSUs granted 59,701 units Restricted stock units granted to director on grant date

Grant price $0.00 per unit Equity compensation, not an open-market purchase

Total holdings after grant 191,842 shares Director’s direct ownership following the award

Vesting schedule Earlier of 1 year or next annual meeting Vesting terms for restricted stock units

Key Terms

restricted stock units, Equity Incentive Plan, vests upon the earlier of

3 terms

restricted stock units financial

"Consists of restricted stock units granted pursuant to the Issuer's 2026 Employee, Director and Consultant Equity Incentive Plan"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Equity Incentive Plan financial

"granted pursuant to the Issuer's 2026 Employee, Director and Consultant Equity Incentive Plan, as amended"

An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.

vests upon the earlier of financial

"and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Newcomer Lee Nisley

(Last) (First) (Middle)

322 NORTH 2200 WEST

(Street)

SALT LAKE CITY UTAH 84116

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MYRIAD GENETICS INC [ MYGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/04/2026		A		59,701(1)	A	$0	191,842	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Consists of restricted stock units granted pursuant to the Issuer's 2026 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant.

Remarks:

	By: Justin Hunter For: Lee Nisley Newcomer	06/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Myriad Genetics (MYGN) director Lee Nisley Newcomer report on this Form 4?

The filing reports a grant of 59,701 restricted stock units to director Lee Nisley Newcomer. These units are part of Myriad Genetics’ 2026 equity incentive plan and increase his direct holdings to 191,842 shares or share-equivalent units after the transaction.

How many restricted stock units did Myriad Genetics (MYGN) grant in this transaction?

Myriad Genetics granted 59,701 restricted stock units in this transaction. Each unit represents a contingent right to receive one share of common stock, awarded at a price of $0.00 per unit as director equity compensation under the 2026 Employee, Director and Consultant Equity Incentive Plan.

When do the restricted stock units for Myriad Genetics (MYGN) director vest?

The restricted stock units vest upon the earlier of two dates. They vest on the first anniversary of the grant date or on the date of the next annual meeting of stockholders following the grant, whichever comes first, aligning vesting with Myriad Genetics’ director service period.

What is Lee Nisley Newcomer’s total Myriad Genetics (MYGN) holding after this Form 4?

After this grant, Lee Nisley Newcomer holds 191,842 Myriad Genetics shares or share-equivalent units directly. This total includes the newly awarded 59,701 restricted stock units, which each convert into one share of common stock once vesting conditions are satisfied under the company’s equity plan.

Was the Myriad Genetics (MYGN) Form 4 a market purchase or a compensation grant?

The Form 4 reflects a compensation grant, not a market purchase. The 59,701 restricted stock units were awarded at $0.00 per share as director equity under the 2026 Employee, Director and Consultant Equity Incentive Plan, representing a non-cash, stock-based compensation transaction.